Masahiro Hasegawa

Dr. Masahiro Hasegawa

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MHMasahiro Hasegawa
Masahiro Hasegawa
TYToshimichi Yoshida
Toshimichi Yoshida
ASAkihiro Sudo
Akihiro Sudo
Tenascin-C (TNC) is a large multimodular glycoprotein of the extracellular matrix that consists of four distinct domains. Emerging evidence suggests that TNC may be involved in the pathogenesis of osteoarthritis (OA) and rheumatoid arthritis (RA). In this review, we summarize the current understanding of the role of TNC in cartilage and in synovial biology, across both OA and RA. TNC is expressed in association with the development of articular cartilage; the expression decreases during maturation of chondrocytes and disappears almost completely in adult articular cartilage. TNC expression is increased in diseased cartilage, synovium, and synovial fluid in OA and RA. In addition, elevated circulating TNC levels have been detected in the blood of RA patients. Thus, TNC could be used as a novel biochemical marker for OA and RA, although it has no specificity as a biochemical marker for these joint disorders. In a post-traumatic OA model of aged joints, TNC deficiency was shown to enhance cartilage degeneration. Treatment with TNC domains results in different, domain-specific effects, which are also dose-dependent. For instance, some TNC fragments including the fibrinogen-like globe domain might function as endogenous inducers of synovitis and cartilage matrix degradation through binding with toll-like receptor-4, while full-length TNC promotes cartilage repair and prevents the development of OA without exacerbating synovitis. The TNC peptide TNIIIA2 also prevents cartilage degeneration without causing synovial inflammation. The clinical significance of TNC effects on cartilage and synovium is unclear and understanding the clinical significance of TNC is not straightforward.

6 April 2004 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
MHMasahiro Hasegawa
Masahiro Hasegawa
ASAkihiro Sudo
Akihiro Sudo
VKVladimir Komlev
Vladimir Komlev
SBSerguei M. Barinov
Serguei M. Barinov
AUAtsumasa Uchida
Atsumasa Uchida

1 July 2006 in The Journal of Bone and Joint Surgery. British volume
Verified
Journal Article
Closed access
PDF file
MHMasahiro Hasegawa
Masahiro Hasegawa
ASA. Sudo
A. Sudo
AUA. Uchida
A. Uchida
A modular layered acetabular component (metal-polyethylene-ceramic) was developed in Japan for use in alumina ceramic-on-ceramic total hip replacement. Between May 1999 and July 2000, we performed 35 alumina ceramic-on-ceramic total hip replacements in 30 consecutive patients, using this layered component and evaluated the clinical and radiological results over a mean follow-up of 5.8 years (5 to 6.5). A total of six hips underwent revision, one for infection, two for dislocation with loosening of the acetabular component, two for alumina liner fractures and one for component dissociation with pelvic osteolysis. There were no fractures of the ceramic heads, and no loosening of the femoral or acetabular component in the unrevised hips was seen at final follow-up. Osteolysis was not observed in any of the unrevised hips. The survivorship analysis at six years after surgery was 83%. The layered acetabular component in our experience, has poor durability because of unexpected mechanical failures including alumina liner fracture and component dissociation.

7 March 2023 in Materials
Verified
Journal Article
Open access
PDF file
MHMasahiro Hasegawa
Masahiro Hasegawa
STShine Tone
Shine Tone
YNYohei Naito
Yohei Naito
ASAkihiro Sudo
Akihiro Sudo
Ultra-high-molecular-weight polyethylene (UHMWPE) wear and particle-induced osteolysis contribute to the failure of total hip arthroplasty (THA) and total knee arthroplasty (TKA). Highly crosslinked polyethylene (HXLPE) was developed in the late 1990s to reduce wear and has shown lower wear rates and loosening than conventional UHMWPE in THA. The irradiation dose for crosslinking is up to 100 kGy. However, during crosslinking, free radical formation induces oxidation. Using HXLPE in THA, the cumulative revision rate was determined to be significantly lower (6.2%) than that with conventional UHMWPE (11.7%) at a mean follow-up of 16 years, according to the Australian Orthopaedic Association National Joint Replacement Registry. However, HXLPE does not confer to TKA the same advantages it confers to THA. Several alternatives have been developed to prevent the release of free radicals and improve polymer mechanical properties, such as thermal treatment, phospholipid polymer 2-methacryloyloxyethyl phosphorylcholine grafting, remelting, and vitamin E addition. Among these options, vitamin E addition has reported good clinical results and wear resistance similar to that of HXLPE without vitamin E, as shown by short-term clinical studies of THA and TKA. This review aims to provide a comprehensive overview of the development and performance of UHMWPE in THA and TKA.

22 January 2009 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
MHMasahiro Hasegawa
Masahiro Hasegawa
YNYutaka Nakoshi
Yutaka Nakoshi
TITakahiro Iino
Takahiro Iino
ASAkihiro Sudo
Akihiro Sudo
TSTatsuya Segawa
Tatsuya Segawa
AUAtsumasa Uchida
Atsumasa Uchida
Objective. Osteopontin (OPN) is an extracellular matrix glycoprotein that has been recognized as a potential inflammatory cytokine. The function of OPN is modulated by protease digestion, and a thrombin-cleaved form of OPN is involved in the pathogenesis of various inflammatory disorders. We examined thrombin-cleaved OPN products in synovial fluid from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Methods. Synovial fluid samples were obtained from knees of 20 patients with RA and 111 patients with OA. Thrombin-cleaved OPN product was determined using Western blotting. Levels of thrombin- cleaved and full-length OPN in synovial fluid were determined by ELISA. Synovia were analyzed by immunohistochemistry using an antibody specific to the thrombin-cleaved form. Results. Immunoblotting showed the presence of thrombin-cleaved OPN in synovial fluid from patients with RA and OA. ELISA results showed no difference between concentrations of full-length OPN in the synovial fluid of RA and OA patients; however, thrombin-cleaved OPN concentrations in RA synovial fluid samples were roughly 30-fold higher compared with OA samples (p < 0.001). Synovial fluid concentrations of thrombin-cleaved OPN in RA did not correlate with C-reactive protein levels. Immunohistochemistry of the synovium showed stronger reactivity in RA than in OA samples. Conclusion. Local generation of thrombin-cleaved OPN was increased in RA joints. Thrombin-cleaved OPN may be a useful biochemical marker of RA.

29 January 2007 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
MHMasahiro Hasegawa
Masahiro Hasegawa
YNYutaka Nakoshi
Yutaka Nakoshi
MMMakoto Muraki
Makoto Muraki
ASAkihiro Sudo
Akihiro Sudo
NKNoriaki Kinoshita
Noriaki Kinoshita
AUAtsumasa Uchida
Atsumasa Uchida
Tenascin‐C (TN‐C) is a hexameric glycoprotein component of extracellular matrix, and alternative RNA splicing creates two major TN‐C size variants (the small and large variants). The large TN‐C variants play key roles in many pathologic conditions in adults, including tumorigenesis, regeneration, and inflammation. This cross‐sectional study compared levels of large TN‐C variants in synovial fluid of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Synovial fluid samples were obtained from knees of 26 patients with advanced RA and 79 with advanced OA. Expression of TN‐C splice variants was examined using Western blotting. The levels of large TN‐C variants in synovial fluid were determined by an enzyme‐linked immunosorbent assay. Synovium were analyzed for TN‐C by immunohistochemistry. Immunoblotting showed the presence of large TN‐C variants in synovial fluid from patients with RA and OA. However, levels of large TN‐C variants were fourfold higher in RA samples compared with OA samples (p < 0.01). Synovial fluid levels of TN‐C in RA did not correlate with C‐reactive protein levels. Immunohistochemistry of the synovium showed stronger reactivity in RA samples than in OA samples. These results indicate that local synthesis of TN‐C is increased during rheumatic disease. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:563–568, 2007